Relationships between heart failure, depression, and anxiety: A Mendelian randomization study

Xi Chen,Xing-Yu Liang,Gui-Lin Zhang,Shu-Yan Wei,Jing-Xia Zou,Hao Liu,Hong Zhang

DOI: https://doi.org/10.1097/md.0000000000040005

IF: 1.6

2024-10-30

Medicine

Abstract:Heart failure (HF) is a major clinical and public health problem, persisting as a major contributor to mortality, morbidity, and poor quality of life. This multifaceted cardiovascular disorder mainly arises from the reduced cardiac output, ventricular remodeling, and neurohormonal activation, resulting in a diminished pumping capacity that fails to adequately meet the body's requirements for oxygen and nutrients. It leads to a clinical syndrome characterized by symptoms like dyspnea or fatigue, and signs such as elevated jugular venous pressure, tachycardia, or peripheral edema. [ 1 ] A comprehensive study indicates that the prevalence of HF ranges between 1% and 3% in the general adult population in industrialized countries. The average incidence of HF was 840/10,000 person-year in adults while 1600/10,000 person-year limited to older adults. And the 1-year case fatality for HF ranged from 4% to 45% with an average of 33% overall. [ 2 ] Despite significant enhancements in HF therapies, morbidity and mortality remain high. Notably, HF emerges as the predominant cause of hospitalization among individuals aged over 65, contributing to 1% to 2% of all hospital admissions, and the annual healthcare costs per HF patient amount up to €25,000 in the Western world. [ 3 ] According to a report from the American Heart Association in 2024, the total direct and indirect costs of heart disease, including HF, were $252.2 billion per year. [ 4 ] These estimates highlight the significant financial burden HF places on both the healthcare system and the economy.

medicine, general & internal